| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 03/09/2005 | CN1191836C Use of hydrogenous medicament active component in medical product preparation |
| 03/08/2005 | US6864228 Use of bisphosphonates for the treatment of osteogenesis imperfecta |
| 03/08/2005 | US6863904 Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
| 03/08/2005 | US6863898 Method and composition for treating hairy hoof warts |
| 03/03/2005 | WO2005019233A1 Mitoquinone derivatives used as mitochondrially targeted antioxidants |
| 03/03/2005 | WO2005019232A1 Mitoquinone derivatives used as mitochondrially targeted antioxidants |
| 03/03/2005 | WO2005018651A1 Pharmaceutical formulation comprising lanthanum compounds |
| 03/03/2005 | WO2005018612A1 Swallowing system tissue modifier |
| 03/03/2005 | WO2005018550A2 Enhancement of magnesium uptake in mammals |
| 03/03/2005 | WO2005018543A2 Silver-containing wound care device, composition therefor, and method of producing |
| 03/03/2005 | WO2004073623A3 Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions |
| 03/03/2005 | WO2003080110A8 Topical pathogenic-tissue-destroying liquid |
| 03/03/2005 | US20050048134 Therapy, prevention of papillomavirus infections; antiinflammatory agents; wound healing agents |
| 03/03/2005 | US20050048132 Use of hydrochloric acid in the preparation of a medicament for the treatment of tumour |
| 03/03/2005 | US20050048131 Anti-virus hydrophilic polymeric material |
| 03/03/2005 | US20050048130 Promotes respiration and results in no deleterious side effects |
| 03/03/2005 | US20050048124 Antimicrobial composition for medical articles |
| 03/03/2005 | US20050048049 A humanized antibody that binds to soluble A beta; may be monoclonal, polyclonal, single chain or fused to a heterologous polypeptide |
| 03/03/2005 | US20050048048 Odor absorbing pad for shoes |
| 03/03/2005 | US20050048014 Bismuth oxychloride compositions and methods of rinsing |
| 03/02/2005 | EP1510216A1 Antithrombogenic platiniferous ceramic composition and article containing the same |
| 03/02/2005 | EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof |
| 03/02/2005 | EP1509238A1 Calcium-containing composition from bone tissue |
| 03/02/2005 | EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis |
| 03/02/2005 | EP1509224A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia |
| 03/02/2005 | EP1326621B1 Medicinal composition and in particular its use in fluid therapy |
| 03/02/2005 | EP1180018B1 Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention and treatment of infections and/ or functional tissue remodelling in the interior of the human body |
| 03/02/2005 | EP1119347B1 Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide |
| 03/02/2005 | EP0844873B1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 03/02/2005 | CN1589149A Reduced toxicity cisplatin formulations and methods for using the same |
| 03/02/2005 | CN1589138A Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 03/02/2005 | CN1589134A Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |
| 03/02/2005 | CN1587059A Process for preparing sunproof skin color zinc oxide nano powder |
| 03/02/2005 | CN1586498A New use of bactericide H4Ag 206 containing silver and its prepared medicine |
| 03/02/2005 | CN1191264C Uridine derivatives as antibiotics |
| 03/02/2005 | CN1191086C Medicine for treating cold in summer and autumn |
| 03/02/2005 | CN1191085C Ointment for treating burns, scalds and knife wound |
| 03/02/2005 | CN1191081C Psoriasis-treating ointment and its compounding process |
| 03/02/2005 | CN1191080C Plaster for treating facial neuritis and its preparing process |
| 03/02/2005 | CN1191076C Medicine specially for treating diabetes |
| 03/02/2005 | CN1191073C Liquid aphtha medicine and its preparing method |
| 03/02/2005 | CN1191016C Method of preparing stable liquid silicate carbonate antibacterial agent |
| 03/01/2005 | US6861076 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 03/01/2005 | US6861073 Dysfunctional satiety center syndrome and method of treatment therefor |
| 03/01/2005 | US6861049 Aqueous slurries useful for cleaning the tongue and throat |
| 02/24/2005 | WO2005016377A1 Topical veterinary compositions and methods for the treatment and prevention of infection |
| 02/24/2005 | WO2005016345A1 Multivitamin syrup for children or young adults |
| 02/24/2005 | WO2005016290A1 Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use |
| 02/24/2005 | WO2005016284A2 Gloves containing dry powdered aloe and method of manufacturing |
| 02/24/2005 | WO2005016271A2 Composition comprising a zeolite compound for treatment of diseases |
| 02/24/2005 | WO2005016265A2 Method for promoting bone growth |
| 02/24/2005 | WO2005016234A2 Compositions, methods, apparatuses, and systems for singlet oxygen delivery |
| 02/24/2005 | WO2005016196A1 Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation |
| 02/24/2005 | WO2005009338A3 Method of inhibiting atf/creb and cancer cell growth and pharmaceutical compositions for same |
| 02/24/2005 | WO2004009064A8 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 02/24/2005 | WO2003099851A3 Methods and compositions for inhibiting hiv replication |
| 02/24/2005 | US20050043413 Active ingredient for producing a substance containing isocitrate for influencing the coagulation tendency of blood |
| 02/24/2005 | US20050043242 Using dietary restriction to lower serum insulin levels and function along with troglitazone in treatment and prevention of alzheimer's diseases |
| 02/24/2005 | US20050042315 Paget's disease; antitumor agents; osteoporesis; nutrient mixture of plant extract and calcium compound |
| 02/24/2005 | US20050042304 Novel substituted benzimidazole dosage forms and method of using same |
| 02/24/2005 | US20050042302 Using organic acid salts for lactate degradation |
| 02/24/2005 | US20050042301 Method of use of Xenon-133 for the treatment of AIDS, other viral and non-viral infections |
| 02/24/2005 | US20050042296 Superfine aqueous dispersion of noble metal for head massage |
| 02/24/2005 | US20050042295 Anti-angiogenic compositions and methods of use |
| 02/24/2005 | US20050042252 Mixture apatite and collagen; crosslinking with glutaraldehyde; ; bones; osteoporosis |
| 02/24/2005 | US20050042237 Method for administering a spill resistant pharmaceutical system |
| 02/24/2005 | US20050042210 Body tissue filling material, production method thereof and body tissue filler |
| 02/24/2005 | US20050042186 Synergistic oil in water emulsions of biomelanin extract, green tea polyphenols and inorganic pigments; improved cytoprotectivity from free radicals; waterproofing |
| 02/24/2005 | US20050042170 Method and device for generating mists and medical uses thereof |
| 02/24/2005 | CA2534950A1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 02/24/2005 | CA2534922A1 Composition comprising a zeolite compound for treatment of diseases |
| 02/23/2005 | EP1508331A1 Method for preparing polymer micelle pharmaceutical preparation containing drug for injection |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507554A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2005 | EP1507544A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/23/2005 | EP1507542A2 Anti-cancer formulation |
| 02/23/2005 | EP1401455B1 Use of a phosphate adsorbent to treat vascular diseases |
| 02/23/2005 | CN1585646A Strontium compound for treatment of sub-dermal soft tissue pain |
| 02/23/2005 | CN1582961A Improved Chinese medicinal paste for arthralgia and its preparation |
| 02/23/2005 | CN1582960A Composite medicine for tooth diseases |
| 02/23/2005 | CN1190232C Wart-removing ointment |
| 02/23/2005 | CN1190217C Medicine for treating dematosis |
| 02/23/2005 | CN1190211C Process for preparing cough-relieving medicine |
| 02/23/2005 | CN1190209C Oral cavity ulcer powder and preparation thereof |
| 02/23/2005 | CN1190208C Medical salt for treating rheumatism |
| 02/23/2005 | CN1190201C Poria type nucleic acid compound preparation and its external application preparation and cosmetics, and their production method |
| 02/23/2005 | CN1190186C Carbohydrate medical solution and sulphite stabilisator in multiple compartment container and use thereof |
| 02/22/2005 | US6858658 Granulated cuprous oxide for antifouling coatings |
| 02/22/2005 | US6858607 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/22/2005 | US6858598 Administering N-hydroxy-2,2-dimethyl-4-((4-(4-pyridinyloxy)phenyl)sulfonyl)-3 -thiomorpholinecarboxamide and an antineoplastic agent selected from irinotecan and topotecan and a combination thereof for therapy of lung cancer |
| 02/22/2005 | US6858236 Nutriceutical and drug compositions containing a plant extract or concentrate from the genus Lycopersicon (tomato); bone disorders, e.g., Paget's disease, tumor-induced bone disease or particularly osteoporosis; metabolic disorders |
| 02/22/2005 | US6858219 Methods for sterilizing male mammals |
| 02/22/2005 | US6858179 Compact, reliable, automated equipment easily deployable in remote locations where simplicity of operation, reliability, and small space requirement are critical; useful aboard ships, in combat support medical units, during humanitarian relief |
| 02/17/2005 | WO2005014856A1 Sensitivity test to predict efficacy of anti-cancer therapies |
| 02/17/2005 | WO2005014770A1 Allergen reducing agent, composition containing same and method for reducing allergen |
| 02/17/2005 | WO2005014034A1 Stabilized formulation of parathyroid hormone |
| 02/17/2005 | WO2005014013A1 Viscosity-stable bismuth-containing pharmaceutical compositions |
| 02/17/2005 | WO2005013980A1 Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions. |
| 02/17/2005 | WO2005013951A2 Pharmaceutical compositions for preventing breast and ovarian cancer |
| 02/17/2005 | WO2005013942A1 Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases |